MAX Chat
Company Analysis Bicycle Therapeutics plc
1. Summary
Advantages
- Price (7.72 $) is less than fair price (14.31 $)
- Current debt level 0.9921% is below 100% and has decreased over 5 years from 1.72%.
Disadvantages
- Dividends (0%) are below the sector average (0.5517%).
- The stock's return over the last year (-62.3%) is lower than the sector average (-45.21%).
- The company's current efficiency (ROE=-29.04%) is lower than the sector average (ROE=111.71%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Bicycle Therapeutics plc | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.9% | -46.7% | -0.6% |
| 90 days | -9.6% | -44.1% | 13.7% |
| 1 year | -62.3% | -45.2% | 20.5% |
BCYC vs Sector: Bicycle Therapeutics plc has significantly underperformed the "Healthcare" sector by -17.09% over the past year.
BCYC vs Market: Bicycle Therapeutics plc has significantly underperformed the market by -82.82% over the past year.
Stable price: BCYC is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BCYC with weekly volatility of -1.2% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (7.72 $) is lower than the fair price (14.31 $).
Price significantly below the fair price: The current price (7.72 $) is 85.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (-2.66) is higher than that of the sector as a whole (-208.2).
P/E vs Market: The company's P/E (-2.66) is higher than that of the market as a whole (-36.78).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.03) is lower than that of the sector as a whole (250.75).
P/BV vs Market: The company's P/BV (1.03) is lower than that of the market as a whole (39.18).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (23.1) is lower than that of the sector as a whole (49.92).
P/S vs Market: The company's P/S indicator (23.1) is lower than that of the market as a whole (140.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0.3343) is lower than that of the sector as a whole (12.66).
EV/Ebitda vs Market: The company's EV/Ebitda (0.3343) is higher than that of the market as a whole (-94.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 46.29% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (46.29%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.25%).
5.4. ROE
ROE vs Sector: The company's ROE (-29.04%) is lower than that of the sector as a whole (111.71%).
ROE vs Market: The company's ROE (-29.04%) is lower than that of the market as a whole (-20.96%).
5.5. ROA
ROA vs Sector: The company's ROA (-21.78%) is lower than that of the sector as a whole (-2.41%).
ROA vs Market: The company's ROA (-21.78%) is lower than that of the market as a whole (40.22%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-27.25%) is lower than that of the sector as a whole (2.44%).
ROIC vs Market: The company's ROIC (-27.25%) is lower than that of the market as a whole (9.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5517%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
